Some reports have shown that dapagliflozin and canagliflozin are able to inhibit the cancer cell proliferation blocking cell cycle in the G1/G0 phase by targeting AMPK/mTOR and inducing apoptosis [155]. This evidence concerns the gene MTOR and cancer.